<div id="hybrid-search-3" class="widget search widget-search"><div class="widget-inside"><form method="get" class="search-form" id="search-form" action="https://rare-diseases.ca/"><div><input class="search-text" type="text" name="s" id="search-text" value="" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" /><input class="search-submit button" name="submit" type="submit" id="search-submit" value="Search" /></div></form><!-- .search-form --></div></div>
Rare Diseases
<div id="hybrid-nav-menu-3" class="widget nav-menu widget-nav-menu"><div class="widget-inside">
</div></div>
<div class="breadcrumb breadcrumbs"><div class="breadcrumb-trail"> » <a href="https://rare-diseases.ca" title="" rel="home" class="trail-begin">Home</a> <span class="sep">»</span> <a href="https://rare-diseases.ca/topics/news-updates/" rel="tag">News & Media</a> <span class="sep">»</span> Wall Street Journal’s Pharmalot – Can Crowdfunding Jumpstart Early Stage Drug Research? </div></div>

Wall Street Journal’s Pharmalot – Can Crowdfunding Jumpstart Early Stage Drug Research?

The article references the recently published paper, Crowdfunding drug development: the state of play in oncology and rare diseases, by Dr. Nick Dragojlovic and Dr. Larry Lynd.

Click here to read the full article from the July 14, 2014 edition of The Wall Street Journal’s Pharmalot.